全球生物電子醫療市場（2023-2030）：按類型（植入式電子醫療設備/非侵入式電子醫療設備）和最終用途（醫院/其他）分類的規模、佔有率、成長分析和預測

Global Bioelectric Medicine Market Size, Share, Growth Analysis, By Type (Implantable electroceutical devices and non-invasive electroceutical devices), By End use(Hospitals and others) - Industry Forecast 2023-2030

出版日期: 2023年10月19日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球生物電子醫療市場規模將從2021年的201億美元成長到2022年的212.7億美元，預測期內年複合成長率為5.8%，預計到2030年將達到333.9億美元。

近年來，由於醫療技術的進步和神經調節研究力度的加大，全球生物電醫學市場出現了顯著成長。成長是由神經系統疾病、心血管疾病和慢性疼痛等慢性疾病推動要素普及所推動的，這些疾病無法透過標準治療方法來解決，而這些疾病正在產生未被滿足的醫療需求。生物電醫學為已經用盡其他選擇的患者提供了一種非侵入性或微創解決方案，並顯示出改善結果和生活品質的潛力。

技術進步

醫療技術的進步，包括更小的設備、更長的電池壽命、無線連接和先進的演算法，大大擴展了生物電子醫學的視野。這些創新不僅提高了生物電設備和治療的準確性和效率，還提高了其易用性，推動市場擴張。

對非侵入性治療的需求不斷成長

由於非侵入性治療具有微創性、副作用減少以及適合家庭和門診使用，因此對非侵入性治療的需求不斷成長，推動了生物電醫學市場的成長。非侵入性電療設備，例如 TENS 設備和 TMS 設備，正變得越來越普及，並在這一擴張中發揮關鍵作用。

本報告調查了全球生物電醫學市場，並提供了市場概況、市場各種影響因素分析、技術和創新趨勢、法律制度、市場規模趨勢和預測，以及各個細分市場和地區的細分。總結了主要企業的細分、競爭形勢和概況。

執行摘要
調查方法
母市場分析
- 市場概況
- 市場規模
- 市場動態
  - 促進因素
  - 機會
  - 抑制因素
  - 任務
關鍵市場洞察
- 技術分析
- 價格分析
- 供應鏈分析
- 價值鏈分析
- 市場生態系統
- 智慧財產權分析
- 貿易分析
- 啟動分析
- 原料分析
- 創新矩陣
- 研發線產品分析
- 總體經濟指標
- 重點投資分析
- 關鍵成功因素
- 競爭程度
- 市場動態及展望
  - 市場動態
    - 促進因素
    - 機會
    - 抑制因素
    - 任務
- 法規狀況
- 波特的分析
- Skyquest 對未來顛覆的獨家見解
全球生物電子醫學市場：按類型
- 市場概況
- 植入式電子醫療設備
- 非侵入性電子醫療設備
全球生物電子醫學市場：依最終用途分類
- 市場概況
- 醫院
- 其他
全球生物電子醫學市場：按地區
- 市場概況
- 北美洲
- 歐洲
- 亞太地區
- 拉丁美洲
- 中東/非洲
競爭形勢
- 前5名企業對比
- 主要企業市場地位
- 主要企業的招募策略
- 關鍵成功策略
- 近期市集活動
- 主要企業市場佔有率
主要企業簡介
- Medtronic PLC
- Abbott Laboratories
- Boston Scientific Corporation
- Nevro Corp
- electroCore LLC
- LivaNova PLC
- Inspire Medical Systems
- Second Sight Medical Products
- Soterix Medical
- NeuroMetrix
- BioControl Medical
- EnteroMedics Inc.
- MicroTransponder
- NDI Medical
- NeuroPace Inc.
- SetPoint Medical
- Galvani Bioelectronics
- Neuronetics Inc.
- Zynex Medical
- Cerbomed GmbH

簡介目錄

Product Code: SQMIG35G2175

Global Bioelectric Medicine Market size was valued at USD 20.1 Billion in 2021 and is poised to grow from USD 21.27 Billion in 2022 to USD 33.39 Billion by 2030, at a CAGR of 5.8% during the forecast period (2023-2030).

The global Bioelectric Medicine market has witnessed substantial growth recently, attributed to advancements in medical technology and increased research efforts in neuromodulation. Bioelectric medicine, or electroceuticals, employs electrical impulses to modulate the nervous system for therapeutic purposes, offering an innovative alternative to conventional pharmaceutical treatments. Its growth is fueled by the growing prevalence of chronic diseases, including neurological disorders, cardiovascular conditions, and chronic pain, which often resist standard therapies, resulting in unmet medical needs. Bioelectric medicine offers a non-invasive or minimally invasive solution for patients who have exhausted other options, potentially improving outcomes and quality of life. Furthermore, technological progress in bioelectric devices and implantable technologies has expanded the potential for targeted therapies.

Top-down and bottom-up approaches were used to estimate and validate the size of the global bioelectric medicine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report

The global bioelectric medicine market is segmented on the basis of type, end use, and region. By type, the market is segmented into implantable electroceutical devices and non-invasive electroceutical devices. By end use, the market is segmented into hospitals and others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers:

Technological Advancements

The evolution of medical technology, marked by the miniaturization of devices, extended battery life, wireless connectivity, and the emergence of advanced algorithms, has greatly broadened the horizons of bioelectric medicine. These innovations not only increase the precision and efficiency of bioelectric devices and treatments but also improve their user-friendliness, thus propelling market expansion.

Growing Demand for Non-Invasive Treatments

The increasing demand for non-invasive treatments, driven by their minimal invasiveness, decreased side effects, and suitability for home or outpatient use, is fueling the growth of the bioelectric medicine market. Non-invasive electroceutical devices like TENS units and TMS devices are becoming more popular and playing a key role in this expansion.

Restraints:

Stringent Regulatory Environment

Navigating the regulatory approval process for bioelectric medicine technologies can be a convoluted and protracted journey, as stringent criteria for safety, effectiveness, and quality must be met before obtaining approvals from regulatory authorities. The arduous compliance with these standards can present formidable obstacles, leading to protracted market entry timelines for innovative products in this field.

High Development and Manufacturing Costs

The substantial financial commitments required for the creation, production, and integration of bioelectric devices pose a formidable hurdle for smaller enterprises and emerging startups seeking to enter the market. The considerable expenses linked to activities such as research and development, clinical trials, and manufacturing can deter their participation in this field.

Market Trends:

The incorporation of bioelectric medicine into telemedicine and digital health solutions is broadening healthcare accessibility while enhancing patient supervision and post-treatment care. Increasingly, remote programming of implantable devices, teleconsultations, and digital platforms for patient education and support are becoming standard practices in the field of bioelectric medicine.

The field of bioelectric medicine is witnessing a substantial influx of investment and funding, with venture capital firms, government agencies, and strategic investors showing growing interest. This heightened awareness of the potential advantages of bioelectric medicine treatments is spurring financial support for research, development, clinical trials, and commercialization initiatives.

Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
- Regulatory Landscape
- Porters Analysis
Competitive rivalry
Threat of Substitute Products
Bargaining Power of Buyers
Threat of New Entrants
Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
Political Impact
Economic Impact
Social Impact
Technical Impact
Environmental Impact
Legal Impact
Global Bioelectric Medicine Market by Type
- Market Overview
- Implantable electroceutical devices and non-invasive electroceutical devices
Global Bioelectric Medicine Market by End use
- Market Overview
- Hospitals and others
Global Bioelectric Medicine Market Size by Region
- Market Overview
- North America
USA
Canada
- Europe
Germany
Spain
France
UK
Rest of Europe
- Asia Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
- Latin America
Brazil
Rest of Latin America
- Middle East & Africa (MEA)
GCC Countries
South Africa
Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
By Development
By Company
By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Medtronic PLC - Ireland
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Abbott Laboratories - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Boston Scientific Corporation - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Nevro Corp - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- electroCore LLC - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- LivaNova PLC - UK
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Inspire Medical Systems - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Second Sight Medical Products - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Soterix Medical - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- NeuroMetrix - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- BioControl Medical - Israel
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- EnteroMedics Inc. - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- MicroTransponder - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- NDI Medical - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- NeuroPace Inc. - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- SetPoint Medical - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Galvani Bioelectronics - United Kingdom
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Neuronetics Inc. - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Zynex Medical - US
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Cerbomed GmbH - Germany
Company Overview
Business Segment Overview
Financial Updates
Key Developments